In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure

Francesca Bortolotti, Laura Ukovich, Vahid Razban, Valentina Martinelli, Giulia Ruozi, Barbara Pelos, Franca Dore, Mauro Giacca, Serena Zacchigna*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

105 Citations (Scopus)

Abstract

Over the last several years, mesenchymal stromal cells (MSCs) have been isolated from different tissues following a variety of different procedures. Here, we comparatively assess the ex vivo and in vivo properties of MSCs isolated from either adipose tissue or bone marrow by different purification protocols. After MSC transplantation into a mouse model of hindlimb ischemia, clinical and histological analysis revealed that bone marrow MSCs purified on adhesive substrates exerted the best therapeutic activity, preserving tissue viability and promoting formation of new arterioles without directly transdifferentiating into vascular cells. In keeping with these observations, these cells abundantly expressed cytokines involved in vessel maturation and cell retention. These findings indicate that the choice of MSC source and purification protocol is critical in determining the therapeutic potential of these cells and warrant the standardization of an optimal MSC isolation procedure in order to select the best conditions to move forward to more effective clinical experimentation.

Original languageEnglish
Pages (from-to)332-339
Number of pages8
JournalStem cell reports
Volume4
Issue number3
DOIs
Publication statusPublished - 1 Jan 2015

Fingerprint

Dive into the research topics of 'In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure'. Together they form a unique fingerprint.

Cite this